Liu Huai-Feng, Zhang Xin-Jiang, Zhang Jian-Li, Hao Zhi-Yong, Zhang Zhi-Yong, Ma Jing-Chen, Chen Ji-Chao, Chu Juan, Wang Xuan-Yi, Xu Zhi-Yi
Zhengding County Hospital of Chinese Medicine, Zhengding, Hebei 050800, Chin.a
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi. 2009 Jun;23(3):180-1.
To observe the immunological effects of three doses of H2 strain live attenuated hepatitis A vaccine 8 years after the administration and to compare with that of one dose of the vaccine.
In a country area, 110 children of 1 to 7 years old susceptible to HAV were screened and administered with one dose of the vaccine, as group B; Group A were 42 children from one of the villages and administered with 3 doses of the vaccine according to 0, 2, 6 month schedule. Blood samples were taken for the children 1, 2, 6, 7, 8, 12, 24, 36 and 96 months after the administrations respectively and detected for anti-HAV antibody.
For group B, the sero conversion rate of anti-HAV and GMC reached peak at 92.2% and 126.2 mIU/ml respectively, and then, began to drop with time; For group A, after 2 dose of the vaccine, the sero-conversion rate reached 100%, and the GMC reached peak of 2 739 mIU/ml one month after the third dose at 7 months. So that, group A has a better short-term immunological effects than that of group B. During 36 through 96 months, the anti-HAV positive rate in group B was 75%-71% and 80-89 mIU/ml respectively, and comparatively in group A were 100% and 918.2-480.6 mIU/ml respectively. The differences between group A and B were significantly important.
A 3-dose schedule administration of H2 strain live attenuated hepatitis A vaccine has better immunological effects than 1-dose schedule in 8years and further observations are needed.
观察甲型肝炎减毒活疫苗H2株3剂次接种8年后的免疫效果,并与1剂次接种效果进行比较。
在某农村地区,筛选出110名1~7岁甲型肝炎病毒(HAV)易感儿童,接种1剂次疫苗作为B组;A组为来自其中1个村庄的42名儿童,按0、2、6月程序接种3剂次疫苗。分别于接种后1、2、6、7、8、12、24、36和96个月采集儿童血样,检测抗-HAV抗体。
B组抗-HAV阳转率和几何平均浓度(GMC)分别于接种后92.2%和126.2 mIU/ml时达到峰值,随后随时间下降;A组接种2剂疫苗后,阳转率达100%,第3剂接种后1个月即7个月时GMC达峰值2 739 mIU/ml。A组短期免疫效果优于B组。在36~96个月期间,B组抗-HAV阳性率分别为75%~71%,GMC为80~89 mIU/ml,而A组分别为100%和918.2~480.6 mIU/ml,A、B组差异有统计学意义。
甲型肝炎减毒活疫苗H2株3剂次接种8年后免疫效果优于1剂次接种,有待进一步观察。